Clinical trial
COMPliance With Avonex® PS in Patients With Relapsing-Remitting MS
NCT00675883 is registered in ClinicalTrials.gov with Biogen as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- COMPliance With Avonex® PS in Patients With Relapsing-Remitting MS
- Lead sponsor
- Biogen
- Phase
- Observational
- Overall status
- Completed
- Start date
- May 31, 2008
- Completion date
- December 31, 2011
- Enrollment
- 1,000 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.